Vanguard Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.2M Sell
9,257,493
-1,410,262
-13% -$7.49M ﹤0.01% 2129
2025
Q1
$94.6M Buy
10,667,755
+76,712
+0.7% +$680K ﹤0.01% 1823
2024
Q4
$145M Buy
10,591,043
+279,379
+3% +$3.83M ﹤0.01% 1687
2024
Q3
$282M Buy
10,311,664
+246,993
+2% +$6.77M 0.01% 1354
2024
Q2
$246M Buy
10,064,671
+28,963
+0.3% +$708K ﹤0.01% 1380
2024
Q1
$214M Buy
10,035,708
+81,475
+0.8% +$1.74M ﹤0.01% 1473
2023
Q4
$191M Buy
9,954,233
+789,496
+9% +$15.1M ﹤0.01% 1531
2023
Q3
$147M Buy
9,164,737
+12,390
+0.1% +$199K ﹤0.01% 1593
2023
Q2
$212M Sell
9,152,347
-146,067
-2% -$3.39M 0.01% 1440
2023
Q1
$216M Sell
9,298,414
-13,347
-0.1% -$310K 0.01% 1411
2022
Q4
$135M Buy
9,311,761
+183,377
+2% +$2.66M ﹤0.01% 1635
2022
Q3
$174M Buy
9,128,384
+121,704
+1% +$2.32M 0.01% 1464
2022
Q2
$164M Buy
9,006,680
+30,087
+0.3% +$547K ﹤0.01% 1551
2022
Q1
$226M Sell
8,976,593
-172,928
-2% -$4.36M 0.01% 1478
2021
Q4
$253M Buy
9,149,521
+116,324
+1% +$3.21M 0.01% 1462
2021
Q3
$292M Buy
9,033,197
+82,377
+0.9% +$2.66M 0.01% 1343
2021
Q2
$274M Buy
8,950,820
+326,155
+4% +$9.97M 0.01% 1427
2021
Q1
$263M Buy
8,624,665
+327,801
+4% +$9.98M 0.01% 1419
2020
Q4
$164M Buy
8,296,864
+298,846
+4% +$5.91M ﹤0.01% 1573
2020
Q3
$104M Sell
7,998,018
-248,394
-3% -$3.24M ﹤0.01% 1673
2020
Q2
$93.5M Sell
8,246,412
-119,035
-1% -$1.35M ﹤0.01% 1713
2020
Q1
$120M Buy
8,365,447
+44,873
+0.5% +$642K 0.01% 1425
2019
Q4
$227M Sell
8,320,574
-329,677
-4% -$8.98M 0.01% 1319
2019
Q3
$248M Buy
8,650,251
+326,482
+4% +$9.35M 0.01% 1204
2019
Q2
$231M Sell
8,323,769
-214,508
-3% -$5.96M 0.01% 1271
2019
Q1
$283M Sell
8,538,277
-654,438
-7% -$21.7M 0.01% 1126
2018
Q4
$267M Buy
9,192,715
+535,782
+6% +$15.6M 0.01% 1059
2018
Q3
$398M Buy
8,656,933
+365,697
+4% +$16.8M 0.02% 918
2018
Q2
$310M Buy
8,291,236
+516,568
+7% +$19.3M 0.01% 1061
2018
Q1
$230M Buy
7,774,668
+550,366
+8% +$16.3M 0.01% 1197
2017
Q4
$248M Buy
7,224,302
+896,790
+14% +$30.8M 0.01% 1157
2017
Q3
$229M Buy
6,327,512
+19,774
+0.3% +$715K 0.01% 1174
2017
Q2
$163M Buy
6,307,738
+56,708
+0.9% +$1.47M 0.01% 1361
2017
Q1
$120M Buy
6,251,030
+897,287
+17% +$17.2M 0.01% 1555
2016
Q4
$89.2M Buy
5,353,743
+158,531
+3% +$2.64M 0.01% 1698
2016
Q3
$107M Sell
5,195,212
-1,454
-0% -$29.9K 0.01% 1518
2016
Q2
$159M Buy
5,196,666
+121,681
+2% +$3.72M 0.01% 1203
2016
Q1
$190M Buy
5,074,985
+221,336
+5% +$8.28M 0.01% 1056
2015
Q4
$209M Buy
4,853,649
+173,406
+4% +$7.48M 0.01% 972
2015
Q3
$175M Sell
4,680,243
-7,432
-0.2% -$279K 0.01% 1077
2015
Q2
$159M Sell
4,687,675
-60,354
-1% -$2.05M 0.01% 1217
2015
Q1
$168M Sell
4,748,029
-4,607
-0.1% -$163K 0.01% 1134
2014
Q4
$162M Sell
4,752,636
-45,831
-1% -$1.56M 0.01% 1101
2014
Q3
$185M Sell
4,798,467
-252,196
-5% -$9.73M 0.01% 980
2014
Q2
$197M Buy
5,050,663
+180,073
+4% +$7.01M 0.02% 968
2014
Q1
$167M Sell
4,870,590
-14,801
-0.3% -$506K 0.01% 1031
2013
Q4
$102M Buy
4,885,391
+45,402
+0.9% +$953K 0.01% 1301
2013
Q3
$114M Buy
4,839,989
+439,892
+10% +$10.3M 0.01% 1157
2013
Q2
$118M Buy
+4,400,097
New +$118M 0.01% 1057